SCHEMBL5575640

SCHEMBL5575640

NC(=O)NN=C(COc1cccc(C(F)(F)F)c1)CP(=O)(O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.57
MAOB P27338 1/20 0.45
AOC3 Q16853 1/20 0.45
LMNA P02545 3/20 0.43
HTT P42858 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
POLB P06746 1/20 0.42
PRSS1 P07477 1/20 0.42
ACR P10323 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
ALDH1A1 P00352 2/20 0.41
GAA P10253 2/20 0.41
MAPT P10636 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TP53 P04637 1/20 0.41
MRGPRX4 Q96LA9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5575636 1.00 KDM4E (0.57) KDM4EMAOBAOC3LMNAHTT
SCHEMBL5575128 0.89 KDM4E (0.54) KDM4EMAOBAOC3LMNAHTT
SCHEMBL5575122 0.89 KDM4E (0.54) KDM4EMAOBAOC3LMNAHTT
SCHEMBL5575155 0.81 KDM4E (0.63) KDM4EMAOBAOC3LMNAHTT
SCHEMBL13960937 0.74 KDM4E (0.76) KDM4EMAOBAOC3LMNAKMT2A
SCHEMBL10932863 0.74 KDM4E (0.71) KDM4EMAOBAOC3LMNAHTT
SCHEMBL13641800 0.74 KDM4E (0.63) KDM4EMAOBAOC3LMNAHTT
SCHEMBL20828383 0.73 KDM4E (1.00) KDM4EMAOBAOC3LMNAKMT2A
SCHEMBL30602684 0.73 KDM4E (1.00) KDM4EMAOBAOC3LMNAKMT2A
SCHEMBL3729578 0.72 KDM4E (0.71) KDM4EMAOBAOC3LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7166730-B2 Process for the preparation of prostaglandin derivatives FINE TECH LABORATORIES, LTD (IL) 2007-01-23 US disclosed
US-20050209337-A1 Process for the preparation of prostaglandin derivatives FINETECH LABORATORIES LTD 2005-09-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050209337-A1 Process for the preparation of prostaglandin derivatives PTGIS, PTGES, PTGIR KDM4E 4475/4885MAOB 1250/4885AOC3 2821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.